Small Animal Imaging In Vivo Market Size, Share, Industry Trends and Forecast to 2030

Small Animal Imaging In Vivo Market Size & CAGR in 2021

The global small animal imaging in vivo market is estimated to have a growth rate of 5.2% CAGR in 2021. The market size is expected to reach USD 1.5 billion by the end of 2021. Small animal imaging in vivo refers to the visualization and analysis of biological processes in living animals using imaging techniques. These techniques help researchers and scientists study the anatomy, physiology, and function of small animals such as mice and rats for various preclinical research applications.

COVID-19 Impact on the Small Animal Imaging In Vivo Market

The COVID-19 pandemic had a significant impact on the small animal imaging in vivo market in 2020 and 2021. Due to the lockdowns and restrictions imposed to curb the spread of the virus, many research laboratories and academic institutions were closed or operating at reduced capacity. This led to disruptions in preclinical research activities, including small animal imaging studies. However, with the gradual reopening of economies and resumption of research activities, the market is expected to recover in the coming years.

Small Animal Imaging In Vivo Dynamics

The small animal imaging in vivo market is driven by the increasing demand for non-invasive imaging techniques in preclinical research. These techniques allow researchers to visualize and track disease progression, treatment response, and the efficacy of drug candidates in living animals. The market is also fueled by advancements in imaging technologies, such as magnetic resonance imaging (MRI), positron emission tomography (PET), and bioluminescence imaging, which offer high resolution and sensitivity for studying small animals.

Segments and Related Analysis

The small animal imaging in vivo market can be segmented based on imaging modality, application, end-user, and region. Imaging modalities include optical imaging, ultrasound imaging, nuclear imaging, and others. Applications of small animal imaging in vivo include oncology, neurology, cardiology, and others. End-users of these imaging techniques include research institutes, pharmaceutical companies, and biotechnology firms.

By Region Analysis

The small animal imaging in vivo market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the market due to the presence of leading research institutions, strong R&D investments, and a well-established healthcare infrastructure. Europe and Asia Pacific are also significant regions for small animal imaging in vivo, driven by increasing research activities and technological advancements.

Key Market Players and Competitive Landscape

Some of the key players in the small animal imaging in vivo market include Bruker Corporation, PerkinElmer Inc., FUJIFILM VisualSonics Inc., MR Solutions Ltd., and Aspect Imaging. These companies focus on product development, partnerships, and acquisitions to strengthen their market position and expand their product offerings. The market is highly competitive, with players striving to innovate and provide advanced imaging solutions for preclinical research.

Recent Happenings in the Small Animal Imaging In Vivo Market

In recent years, the small animal imaging in vivo market has witnessed several developments and innovations. For example, Bruker Corporation launched the In-Vivo Xtreme II imaging system, a high-performance preclinical imaging platform for small animal research. PerkinElmer Inc. introduced the IVIS Lumina S5 bioluminescence and fluorescence imaging system for longitudinal monitoring of disease progression in small animals. These advancements highlight the continuous efforts to enhance imaging technologies for preclinical research applications.